PROTEGO BIOPHARMA
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
PROTEGO BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.protegobiopharma.com
Total Employee:
1+
Status:
Active
Contact:
858-242-1518
Total Funding:
51.05 M USD
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vida Ventures
Vida Ventures investment in Series A - Protego Biopharma
MPM Capital
MPM Capital investment in Series A - Protego Biopharma
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - Protego Biopharma
Official Site Inspections
http://www.protegobiopharma.com
- Host name: apache2-pat.pdx1-shared-a4-08.dreamhost.com
- IP address: 64.90.52.207
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Protego Biopharma"
Protego Biopharma - Crunchbase Company Profile
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.See details»
Protego
Proteins are the molecular engines of human biology, responsible for a wide range of essential physiological processes. The structural integrity of proteins is critical to their biological …See details»
PROTEGO BIOPHARMA, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PROTEGO BIOPHARMA, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Protego Biopharma - Funding, Financials, Valuation & Investors
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.See details»
Protego Biopharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 10945 Vista Sorrento Parkway . San Diego, California, 92130, United States (858) 355-9290See details»
Protego Biopharma (fka Misfolding Diagnostics) | VentureRadar
"Protego Biopharma focuses on the discovery and development of first- or best-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various …See details»
Protego Biopharma - LinkedIn
Protego Biopharma | 1,208 followers on LinkedIn. The small molecule pharmacological chaperone company | Protego Biopharma focuses on the discovery and development of small-molecule …See details»
Protego Biopharma Raises $51 Million Series A Financing to …
Nov 17, 2021 - Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering …See details»
Protego Biopharma Raises $51 Million Series A Financing to
Nov 17, 2021 - Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering …See details»
Protego Biopharma - Contacts, Employees, Board Members
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.See details»
Protego Biopharma - Overview, News & Similar companies
Protego Biopharma contact info: Phone number: (858) 242-1518 Website: www.protegobiopharma.com What does Protego Biopharma do? Protego Biopharma focuses …See details»
FCOI POLICY - Protego
Institution – means any domestic or foreign, public or private, entity or organization (excluding a Federal agency) applying for, or receiving NIH research funding. ...See details»
Protego Biopharma: Contact Details and Business Profile
Protegobiopharma.com; Chiara Tommasi Associate Research Scientist at Protego Biopharma San Diego, CA, US View. View Similar People. Related Companies Mainstay Medical. 134 …See details»
Protego Biopharma Raises $51 Million Series A Financing to
Nov 17, 2021 - Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering …See details»
Protego Biopharma - Craft
Protego Biopharma is a preclinical-stage biotechnology company that develops pharmacological chaperone screening platforms. It offers systemic amyloid and protein misfolding diseases …See details»
Protego Bio - LinkedIn
Protego Bio Biotechnology Research San Diego, California 1,864 followers The small molecule pharmacological chaperone companySee details»
Protego Biopharma - PitchBook
Protego Biopharma General Information Description. Developer of small molecule therapeutics platform designed to reprogram protein folding for the treatment of various systemic amyloid …See details»
Occam Recruits Brent Warner as CEO for Protego Biopharma
In April 2024, Occam Global placed Brent Warner as CEO of Protego Biopharma, an emerging biotech company in preclinical stage. With groundbreaking science originating from Jeff Kelly’s …See details»
Protego Biopharma’s $51M Series A Financing - Brown Rudnick
Protego, a preclinical-stage biotechnology company dedicated to finding novel solutions for protein misfolding diseases, announced on Nov. 17 the completion of a $51 million Series A …See details»
Protego unfolds a $51M series A - BioWorld
Protego Biopharma Inc. raised $51 million in a series A financing to advance the targeting of protein misfolding diseases. The fundraising is a few years on from 2017, when the idea …See details»